share_log

康龙化成(03759.HK)8月27日举行董事会会议审议及批准中期业绩

Pharmaron (03759.HK) held a board of directors meeting on August 27 to review and approve its mid-term performance.

Gelonghui Finance ·  Aug 14 04:32

Pharmaron (03759.HK) announced on August 14th that the board of directors meeting will be held on Tuesday, August 27th, 2024 to review and approve the interim performance of the company and its subsidiaries for the six months ended June 30th, 2024, which includes its release.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment